haloperidol has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Kim, FJ; Lou, R; Oyer, HM; Salvino, JM; Srikanth, YVV | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for haloperidol and mdv 3100
| Article | Year |
|---|---|
Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer.
Topics: Animals; ERG1 Potassium Channel; Guanidines; Half-Life; Humans; Male; Mice; Microsomes, Liver; Neoplasm Staging; Prostatic Neoplasms; Protein Binding; Receptors, sigma; Sigma-1 Receptor; Structure-Activity Relationship | 2017 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |